RKDA — Arcadia Biosciences Cashflow Statement
0.000.00%
- $7.49m
- $3.05m
- $5.05m
- 15
- 44
- 33
- 20
Annual cashflow statement for Arcadia Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.03 | -16.1 | -15.6 | -14 | -7.04 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -12.4 | -6.52 | 1.04 | 1.91 | -1.26 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.4 | -4.26 | 0.118 | -3.51 | -1.45 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -30.2 | -25.9 | -14 | -15.3 | -9.63 |
| Capital Expenditures | -2.33 | -1.01 | -0.072 | -0.005 | -0.016 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 19.6 | 17.6 | 1.49 | -4.34 | 7.36 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 17.3 | 16.6 | 1.42 | -4.34 | 7.34 |
| Financing Cash Flow Items | 0.063 | -1.16 | -0.488 | -0.497 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.6 | 21.9 | 4.52 | 5.51 | 0.009 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.63 | 12.6 | -8.04 | -14.1 | -2.28 |